Publication | Closed Access
HMGA1 silencing reduces stemness and temozolomide resistance in glioblastoma stem cells
41
Citations
33
References
2016
Year
These results demonstrate a pivotal role of HMGA1 in cancer stem cell gliomagenesis and endorse HMGA1 as a suitable target for CSC-specific GBM therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1